Developing technologies for nutrition, infection, and cancer care worldwide
Point of Care Technologies for Nutrition, Infection, and Cancer for Global Health (PORTENT)
This study is working on new health tools that can help people around the world with nutrition, infections, and cancer, making it easier for patients to get better care and treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Cornell University NIH-funded |
| Lab location | 1 site (Ithaca, United States) |
| Project ID | NIH-10928889 on NIH RePORTER |
What this research studies
This research focuses on creating point-of-care technologies that can improve health outcomes related to nutrition, infections, and cancer on a global scale. It involves collaboration among leading institutions, including Cornell, Columbia, and McGill, to assess needs and develop innovative solutions tailored to various populations. The project aims to streamline the administration and execution of health initiatives by leveraging established relationships with clinical sites and advisory boards. Patients may benefit from new diagnostic tools and treatment options that are more accessible and effective.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals affected by nutritional deficiencies, infectious diseases, or cancer, particularly in underserved regions.
Not a fit: Patients with conditions unrelated to nutrition, infection, or cancer may not receive direct benefits from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved health outcomes and access to care for patients suffering from nutrition-related issues, infections, and cancers.
How similar studies have performed: Previous research has shown promise in developing point-of-care technologies for similar health challenges, indicating a potential for success in this approach.
Where this research is happening
Ithaca, United States
- Cornell University — Ithaca, United States (Active)
Researchers
- Principal investigator: Erickson, David Carl — Cornell University
- Study coordinator: Erickson, David Carl
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.